FPS
HAE icon

Fieldpoint Private Securities’s Haemonetics HAE Stock Holding History

Fieldpoint Private Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Sell
20
-65
-76% -$3.85K ﹤0.01% 1342
2022
Q1 		$5K Buy
+85
New +$4.62K ﹤0.01% 1272
2021
Q3 		– Sell
-20
Closed -$1K – 1668
2021
Q2 		$1K Sell
20
-35
-64% -$2.48K ﹤0.01% 1478
2021
Q1 		$6K Hold
55
– – ﹤0.01% 1141
2020
Q4 		$7K Buy
+55
New +$5.92K ﹤0.01% 1022

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fieldpoint Private Securities's HAE Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Haemonetics (HAE) stake by 76% in Q2 2022, selling an estimated $3.85K and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Fieldpoint Private Securities first reported a position in HAE in Q4 2020 and has held it in 5 quarters since. The position peaked at $7K in Q4 2020. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

  • Fieldpoint Private Securities held 20 shares of Haemonetics worth $1K as of Q2 2022.
  • Fieldpoint Private Securities sold 65 Haemonetics shares in Q2 2022, an estimated $3.85K.
  • Haemonetics made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1342 holding.
  • Fieldpoint Private Securities first reported a position in Haemonetics in Q4 2020 and has held it in 5 quarters since.
  • Fieldpoint Private Securities's Haemonetics position peaked at $7K in Q4 2020.
  • 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.